Search results
Results from the WOW.Com Content Network
U.S. government researchers have found that a widely prescribed asthma drug originally sold by Merck & Co may be linked to serious mental health problems for some patients, according to a ...
Rates of asthma have plateaued in the developed world since the mid-1990s with recent increases primarily in the developing world. [289] Asthma affects approximately 7% of the population of the United States [203] and 5% of people in the United Kingdom. [290] Canada, Australia and New Zealand have rates of about 14–15%. [291]
The World Health Organization (WHO) reports that some 10% of the Swiss population have asthma as of 2007, compared with 2% some 25–30 years ago. [11] In the United States the age-adjusted prevalence of asthma increased from 7.3 to 8.2 percent during the years 2001 through 2009.
In today’s world, information travels fast, aided by mass media and social media dissemination. ... those who disseminate health information, such as medical news websites like ours, have a duty ...
Nucala, known also as mepolizumab, was first approved in 2015 for a type of severe asthma in the United States. Its sales grew 18% to 1.7 billion pounds in 2023. It contributed nearly 6% to GSK ...
GINA conducts continuous review of scientific publications on asthma and is a leader in disseminating information about the care of patients with asthma. [2] GINA publishes resources such as evidence-based guidelines for asthma management, and runs special events such as World Asthma Day. GINA's guidelines, revised each year, are used by ...
Nationally, asthma-associated ER visits were 17% higher than normal during 19 days of wildfire smoke that occurred between late April and early August, according to one CDC study that drew data ...
The Asthma and Allergy Foundation of America (AAFA) is the leading patient organization for people with asthma and allergies and the oldest asthma and allergy patient group in the world. AAFA is dedicated to saving lives and reducing the burden of disease for people with asthma, allergies, and related conditions through research, education ...